Month: July 2020

– Revenus totaux de 17,2 millions, en hausse de 10 % par rapport au deuxième trimestre de 2019 et en hausse de 9 % par rapport au premier trimestre de 2020 –– Hausse de 13,2 % des revenus nets de TrogarzoMD et hausse de 7,3 % des revenus nets d’EGRIFTAMD et d’EGRIFTA SVMD par rapport au deuxième trimestre de 2019 –– Aucun impact sur la chaîne d’approvisionnement et les stocks de produits en raison de la pandémie de COVID-19 –MONTRÉAL, 15 juill. 2020 (GLOBE NEWSWIRE) — Theratechnologies inc. (« Theratechnologies », ou la « Société ») (TSX : TH) (NASDAQ : THTX), société biopharmaceutique au stade de l’exploitation commerciale, a annoncé aujourd’hui ses résultats financiers pour le deuxième trimestre de l’exercice 2020 clos le 31 mai 2020.« Bien que la pandémie ait occasionné de nombreux défis pour...

MISSISSAUGA, Ontario, July 15, 2020 (GLOBE NEWSWIRE) — KP Tissue Inc. (“KPT”) (TSX:KPT), which holds a limited partnership interest in Kruger Products L.P. (“KPLP”), will release the financial results for KPT and KPLP for the second quarter of 2020 on Thursday, August 6, 2020 before the market opens. KPT will hold its conference call the same day at 8:30 a.m.  Eastern Time.Details of the Conference CallVia telephone: 1- 877-223-4471 or 647-788-4922Via the internet at: www.kptissueinc.comPresentation material referenced during the conference call will be available at www.kptissueinc.com.Conference Call RebroadcastA rebroadcast of the conference call will be available until midnight, August 13, 2020 by dialing 1-800-585-8367 or 416-621-4642 and entering passcode­­ 1935229.The replay of the webcast will remain available on the web...

MISSISSAUGA, Ontario, 15 juill. 2020 (GLOBE NEWSWIRE) — Papiers Tissu KP inc. (TSX : KPT) (« PTKP »), qui détient un intérêt limité dans Produits Kruger S.E.C (« PK S.E.C. »), publiera les résultats financiers de PTKP et de PK S.E.C. pour le deuxième trimestre de l’exercice 2020 le jeudi 6 août 2020, avant l’ouverture de la séance. PTKP tiendra une téléconférence cette même journée, à 8 h 30, heure de l’Est.Renseignements sur la téléconférence (en anglais seulement)Au téléphone : 1- 877-223-4471 ou 647-788-4922Sur le site Web : www.kptissueinc.comLes documents auxquels on fera référence lors de la téléconférence seront disponibles au www.kptissueinc.com.Téléconférence archivéeLa téléconférence sera disponible jusqu’à minuit le 13 août 2020 et il sera possible d’y accéder en composant le 1-800-585-8367 ou le 416-621-4642 et...

SAN CLEMENTE, Calif., July 15, 2020 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its second quarter 2020 earnings release and conference call.The Company will release its second quarter 2020 results on Monday, August 10th, 2020 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Monday, August 10th, 2020. The call can be accessed at (800) 936-9761, conference ID 4305099. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company’s website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast...

ROCHESTER, N.Y., July 15, 2020 (GLOBE NEWSWIRE) — Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, will release its fiscal 2021 first quarter earnings on July 29, 2020. The Company will host a conference call and audio webcast on Wednesday, July 29, 2020 at 8:30 a.m. Eastern Time.The conference call may be accessed by dialing 1-877-425-9470 and using the required passcode 13706976. A replay will be available approximately two hours after the recording through Wednesday, August 12, 2020 and can be accessed by dialing 1-844-512-2921 and using the required passcode of 13706976. The live conference call and replay can also be accessed via audio webcast at the Investors section of the Company’s website, located at corporate.monro.com. An archive will be available at this website through...

CANTON, Mass., July 15, 2020 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported preliminary revenue results for the three months ended June 30, 2020. Second Quarter 2020 Preliminary Revenue Summary:Net revenue of between $68.0 million and $68.6 million for the three months ended June 30, 2020, up 5% to 6% compared to net revenue of $64.9 million for the three months ended June 30, 2019.  Net revenue is based upon:Net revenue from Advanced Wound Care products of between $59.7 million and $60.1 million, up 8% to 9% year-over-year.Net revenue from Surgical & Sports Medicine products of between $8.3 million...

MONTREAL, July 15, 2020 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) and its wholly owned subsidiary 1178991 CANADA INC. (“Knight“) today announced the launch of the tender offer and the release of the notice for the tender offer process filed by 1178991 CANADA INC. for the acquisition and delisting of all outstanding Brazilian Depositary Receipts of Biotoscana Investments S.A.In connection with the tender offer, the auction will take place on August 14, 2020. Settlement will be completed within 2 business days following the auction.About Knight Therapeutics Inc.Knight Therapeutics Inc., headquartered in Montreal, Canada, is a pan-American (ex-US) specialty pharmaceutical company focused on developing, acquiring or in-licensing and commercializing innovative pharmaceutical products for Canada and Latin America....

MONTRÉAL, 15 juill. 2020 (GLOBE NEWSWIRE) — Thérapeutique Knight inc. (TSX : GUD) et sa filiale en propriété exclusive 1178991 CANADA INC. (« Knight ») a annoncé aujourd’hui le lancement d’une offre publique d’achat et la publication de l’avis de procédure d’offre publique d’achat déposé par 1178991 CANADA INC. pour l’acquisition et le retrait d’inscription de tous les certificats de dépôt brésiliens en circulation de Biotoscana Investments S.A.Dans le cadre de l’offre publique d’achat, la vente aux enchères se déroulera le 14 août 2020. Le règlement sera conclu dans les 2 jours ouvrables suivant la vente aux enchères.À propos de Thérapeutique Knight inc.Thérapeutique Knight inc., établie à Montréal, au Canada, est une société pharmaceutique spécialisée panaméricaine (ex. ÉU) qui concentre ses efforts sur le développement, l’acquisition...

Highlights:Q2 2020 exploration program returned outstanding results with near-surface, high-grade gold intersections in all targeted areas; Midfield SE, Striker SW and Dark HorseIntersected anomalous gold in all 11 holes in a 100m x 50m area, within 25 metres of surface at Striker SW      ♦ BKD-292 intersected 15 metres of 29 g/t gold beginning 0.9 metres from drill collar, including one metre of 353 g/t goldAlong with recent results from the new Midfield SE zone, drilling has expanded gold mineralization in areas of the Bayan Khundii resource currently classified mainly as sub-grade materialDiscovery of high-grade zones in trenches confirms the Dark Horse prospect as the best on-license target since the discovery of Bayan KhundiiMultiple highly prospective targets to be drilled as part of Q3 2020 exploration programHALIFAX, Nova Scotia,...

SAINT-MICHEL-DES-SAINTS, Quebec, July 15, 2020 (GLOBE NEWSWIRE) — Nouveau Monde Graphite (“Nouveau Monde” or “NMG”) (TSXV: NOU; OTCQX: NMGRF; Frankfurt: NM9) is pleased to announce that it has successfully agreed with The Pallinghurst Group (“Pallinghurst”) financing transactions totaling C$20 million that will fund the next phase of NMG’s development. Nouveau Monde has entered into a convertible bond subscription agreement (the “Subscription Agreement”) with Pallinghurst pursuant to which NMG has agreed to issue to Pallinghurst a secured convertible bond in the principal amount of C$15 million (the “Bond Transaction”). Concurrently, Nouveau Monde has also entered into a royalty purchase agreement with Pallinghurst pursuant to which Pallinghurst has agreed to exchange the...